The progression of AIDS seems to depend on variantes of the INFG gene.
1. |
He W et al. (2008) Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. |
2. |
Granelli-Piperno A et al. (2006) HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. |
3. |
Schindler M et al. (2006) Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. |
4. |
Cressey TR et al. (2007) Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update. |
5. |
Jennes W et al. (2006) Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. |
6. |
Wilkin TJ et al. (2007) HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211. |
7. |
Zhou T et al. (2007) Structural definition of a conserved neutralization epitope on HIV-1 gp120. |
8. |
Hladik F et al. (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. |
9. |
Triboulet R et al. (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. |
10. |
Gulick RM et al. (2007) Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211. |
11. |
Jiménez-Baranda S et al. (2007) Filamin-A regulates actin-dependent clustering of HIV receptors. |
12. |
Fellay J et al. (2007) A whole-genome association study of major determinants for host control of HIV-1. |
13. |
Huang J et al. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. |
14. |
Brass AL et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. |
15. |
Burt TD et al. (2008) Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. |
16. |
Gao X et al. (2005) AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. |
17. |
Mandl JN et al. (2008) Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. |
18. |
Kulkarni H et al. (2009) The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. |
19. |
Manganaro L et al. (2010) Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes. |
20. |
Kosmrlj A et al. (2010) Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. |
21. |
Cagliani R et al. (2010) Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection. |
22. |
Zhang W et al. (2011) T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction. |
23. |
Jäger S et al. (2011) Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. |
24. |
Richardson MW et al. (2012) Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection. |
25. |
Harman AN et al. (2015) HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1. |
26. |
Yoh SM et al. (2015) PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1. |
27. |
Sperandio S et al. (2015) TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability. |
28. |
Usami Y et al. (2015) SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. |
29. |
Rosa A et al. (2015) HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. |
30. |
Ramsuran V et al. (2018) Elevated expression impairs HIV control through inhibition of NKG2A-expressing cells. |
31. |
Migueles SA et al. (2000) HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. |
32. |
Shin HD et. al. (2000) Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. |
33. |
Carrington M et al. (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. |
34. |
Thomas R et al. (2009) HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. |
35. |
Vasilescu A et al. (2007) A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients. |
36. |
An P et al. (2003) A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals. |
37. |
Sironi M et al. (2012) A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. |
38. |
Yan N et al. (2010) The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. |
39. |
Samson M et al. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. |
40. |
Liu R et al. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. |
44. |
Martin MP et al. (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. |
45. |
Liu H et al. (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. |
46. |
Rosenwasser LJ et. al. (1997) Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). |
47. |
Faure S et al. (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. |
48. |
Gao X et al. (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. |
49. |
An P et al. (2002) Modulating influence on HIV/AIDS by interacting RANTES gene variants. |
50. |
Martin MP et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. |
51. |
Modi WS et al. (2003) MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. |
52. |
O'Brien SJ et al. (2004) Human genes that limit AIDS. |
53. |
Nolan D et al. (2004) Impact of host genetics on HIV disease progression and treatment: new conflicts on an ancient battleground. |
54. |
None (2004) HIV-host interactions: vital to the virus and key to its inhibition. |
55. |
Lassen K et al. (2004) The multifactorial nature of HIV-1 latency. |
56. |
Martin MP et al. (2004) Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. |
57. |
Kaslow RA et al. (2005) Influence of host genetic variation on susceptibility to HIV type 1 infection. |
58. |
Gonzalez E et al. (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. |
59. |
Colobran R et al. (2005) Multiple products derived from two CCL4 loci: high incidence of a new polymorphism in HIV+ patients. |
60. |
Soriano A et al. (2005) Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS. |